These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31002131)

  • 1. Clinicopathological and prognostic significance of miR-4317 expression in gastric cancer patients.
    Zhang J; Tian ZL; Zhang WT; Cheng LM; Liu J; Cao YX; Zhang ZR
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2803-2808. PubMed ID: 31002131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of miR-1236-3p is correlated with clinical progression and unfavorable prognosis in gastric cancer.
    Zhu XP; Wang XL; Ma J; Fang YF; Zhang HJ; Zhang C; Feng MC
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5914-5919. PubMed ID: 30280772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of miR-181d is associated with poor prognosis and tumor progression of gastric cancer.
    Li Z; Guo Q; Lu Y; Tian T
    Cancer Biomark; 2019; 26(3):353-360. PubMed ID: 31524144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
    An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
    Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of miR-601 is associated with poor prognosis and tumor progression of gastric cancer.
    Min C; Zhang A; Qin J
    Diagn Pathol; 2019 Sep; 14(1):107. PubMed ID: 31547835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of miR-141 downregulation in gastric cancer.
    Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X
    Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
    Li J; Zou X
    Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer.
    Zhang Y; Wen X; Hu XL; Cheng LZ; Yu JY; Wei ZB
    Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3026-30. PubMed ID: 27460730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-1298 expression correlates with prognosis and inhibits cell proliferation and invasion of gastric cancer.
    Qiu ZK; Liu N; Zhao SF; Ding AP; Cheng G; Qiu WS; Qi WW
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1672-1679. PubMed ID: 29630111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of miR-519a Predicts Poor Prognosis and Contributes to Tumor Progression in Gastric Cancer.
    Cai H; Lin H; Cao W; Sun J; Huang Y; Fang Y
    Oncol Res Treat; 2020; 43(1-2):19-26. PubMed ID: 31743914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
    Kong Y; Ning L; Qiu F; Yu Q; Cao B
    Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-451, a potential prognostic biomarker and tumor suppressor for gastric cancer.
    Su Z; Zhao J; Rong Z; Geng W; Wang Z
    Int J Clin Exp Pathol; 2015; 8(8):9154-60. PubMed ID: 26464660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of miR-552 Predicts Unfavorable Prognosis of Gastric Cancer and Promotes the Proliferation, Migration, and Invasion of Gastric Cancer Cells.
    Feng X; Zhu M; Liao B; Tian T; Li M; Wang Z; Chen G
    Oncol Res Treat; 2020; 43(3):103-111. PubMed ID: 31958799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.
    Yang Q; Zhang C; Huang B; Li H; Zhang R; Huang Y; Wang J
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):953-7. PubMed ID: 23751352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
    Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
    Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation miR-539 is associated with poor prognosis of gastric cancer patients and aggressive progression of gastric cancer cells.
    Jin W; Han H; Liu D
    Cancer Biomark; 2019; 26(2):183-191. PubMed ID: 31403943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased miR-198 expression and its prognostic significance in human gastric cancer.
    Cui Z; Zheng X; Kong D
    World J Surg Oncol; 2016 Feb; 14():33. PubMed ID: 26852230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum miR-200c expression level as a prognostic biomarker for gastric cancer.
    Zhang HP; Sun FB; Li SJ
    Genet Mol Res; 2015 Dec; 14(4):15913-20. PubMed ID: 26662382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer.
    Ma G; Dai W; Sang A; Yang X; Gao C
    Int J Clin Exp Pathol; 2014; 7(12):8833-40. PubMed ID: 25674252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
    Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
    Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.